Structure Therapeutics FY 2023: net loss $89.6M; diluted EPS −$0.81

Key figures from this report

These are the numbers Structure Therapeutics reported for the year ended Dec 31, 2023, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income−$89.6MNo year-earlier figure tagged10-K income statement, on EDGAR
2. Diluted EPS−$0.81No year-earlier figure tagged10-K income statement, on EDGAR
3. Cash and cash equivalents$129.8MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
4. Cash from operations−$79.5MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables